Synthesis and proapoptotic properties of new casein kinase II inhibitors

Acta Poloniae Pharmaceutica - Drug Research

Volumn 67, Issue 6, 2010, Pages 635-641

  Koronkiewicz, Mirosława ^a   Zukowska, Magda ^a   Chilmonczyk, Zdzisław ^a   Orzeszko, Andrzej ^b,c   Kazimierczuk, Zygmunt ^b  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

^b WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

^c MILITARY UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Apoptosis; Casein kinase II; CK2; CK2 inhibitors; Tetrabromobenzimidazoles; Tetraiodobenzimidazoles

Indexed keywords

4,5,6,7 TETRABROMO 2 (4 METHYLPIPERAZIN 1 YL) 1H BENZIMIDAZOLE; 4,5,6,7 TETRABROMOBENZIMIDAZOLE; 4,5,6,7 TETRAIODO 2 (4 METHYLPIPERAZIN 1 YL) 1H BENZIMIDAZOLE; 4,5,6,7 TETRAIODOBENZIMIDAZOLE; CASEIN KINASE II; CASEIN KINASE II INHIBITOR; ONCOPROTEIN; PHOSPHOTRANSFERASE INHIBITOR; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL STRAIN HL 60; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; MITOCHONDRIAL MEMBRANE POTENTIAL; MONOTHERAPY; SIGNAL TRANSDUCTION; TIME;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZIMIDAZOLES; CASEIN KINASE II; CELL CYCLE; DOSE-RESPONSE RELATIONSHIP, DRUG; HL-60 CELLS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MEMBRANE POTENTIAL, MITOCHONDRIAL; PROTEIN KINASE INHIBITORS; TIME FACTORS;

EID: 78049245996     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Meggio F., Pinna L.A.: FASEB J. 17, 349 (2003).
2. Litchfield D.W.: Biochem. J. 369, 1 (2003).
3. Duncan J.S., Litchfield D.W.: Biochim. Biophys. Acta 1784, 33 (2008).
4. Guerra B., Issinger O.G.: Electrophoresis 20, 391 (1999).
5. Tawfic S., Yu S., Wang H., Faust R., Davis A., Ahmed K.: Histol. Histopathol. 16, 573, (2001).
6. Ahmad K.A., Wang G., Slaton J., Unger G., Ahmed K.: Anticancer Drugs 16, 1037 (2001).
7. Yu M., Yeh J., Van Waes C.: Cancer Res. 66, 6722 (2001).
8. Ławnicka H., Kowalewicz-Kulbat M., Sicińska P., Kazimierczuk Z., Grieb P., Stepień H.: Cell Tissue Res. 340, 371, (2010).
9. Faust M., Montenarh M.: Cell Tissue Res. 301, 329 (2000).
10. O-charoenrat P., Rusch V., Talbot S.G., Sarkaria I., Viale A., Socci N., Ngai I., Rao P., Singh B.: Clin. Cancer Res. 10, 5792 (2004).
11. Kim J.S., Eom J.I., Cheong J.W., Choi A.J., Lee J.K., Yang W.I., Min Y.H.: Clin. Cancer Res. 13, 1019 (2007).
12. Laramas M., Pasquier D., Filhol O., Ringeisen F., Descotes J.L., Cochet C.: Eur. J. Cancer 43, 928 (2007).
13. Wang G., Unger G., Ahmad K.A., Slaton J.W., Ahmed K.: Mol. Cell Biochem. 274, 77 (2005).
14. Sarno S., Pinna L.A.: Mol. Biosyst. 4, 889 (2008).
15. Mishra S., Pertz V., Zhang B., Kaur P., Shimada H., Groffen J., Kazimierczuk Z., Pinna L.A., Heisterkamp N.: Leukemia 21, 178 (2007).
16. Battistutta R., Mazzorana M., Cendron L., Bortolato A., Sarno S., Kazimierczuk, Z., Zanotti G., Moro S., Pinna L. A.: ChemBioChem. 8, 1804 (2007).
17. Mazzorana M., Pinna L.A.: Mol. Cell. Biochem. 316, 57 (2008).
18. Gianoncelli A., Cozza G., Orzeszko A., Meggio F., Kazimierczuk Z., Pinna L.A.: Bioorg. Med. Chem. 17, 7281 (2009).
19. Pagano M.A., Andrzejewska M., Ruzzene M., Sarno S., Cesaro L., Bain J., Elliott M., Meggio F., Kazimierczuk Z., Pinna L.A.: J. Med. Chem. 47, 6239 (2004).